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Background: Placebo-controlled trials are an important tool when assessing the efficacy of spinal surgical pro-
cedures. The most common spinal surgical procedure in older adults is decompression for lumbar spinal stenosis.
Before conducting a placebo-surgical trial on decompression surgery, an investigation of patients’ willingness to
participate in a placebo-controlled trial of decompression surgery and barriers to participation were explored.
Materials: An online survey.
Methods: Descriptive analyses of demographic and clinical data, and participants' willingness to participate in a
placebo-surgical trial. Logistic regression was used to examine potential predictors of willingness to participate.
Two independent researchers performed a coded framework analysis of patients’ barriers to participation.
Results: 68 patients were invited and 63 participants completed the survey (91.3% response, mean (SD) age 69.5
(10.9) years, 52% females), 71% suffered from moderate to very severe pain. Ten participants (15.9%) were
willing to participate in a placebo-controlled trial. Being married was associated with decreased odds of
participating (OR: 0.2; 95% CI, 0.05 to 0.8; P ¼ 0.03), while the main barriers were a lack of information about
the procedure, reassurance of a positive outcome with participation, and concerns about the risks and benefits of
placebo surgery.
Conclusions: A minority of patients with lumbar spinal stenosis were willing to participate in a placebo-controlled
trial of surgery. The identified barriers indicate that educating eligible patients about: the need for placebo-
surgical trials, the personal risks and benefits of participation, and the importance and potential benefits of
placebo trials to others, may be crucial to ensure adequate recruitment into the placebo-controlled surgical trial.
Conclusions should be read cautiously however, given the small sample size present in this study.1. Background
Placebo-controlled trials are an invaluable tool for evaluating the
efficacy of a surgical procedure [1, 2, 3]. The inclusion of placebo allows
for more reliable blinding of participants and outcome assessors than
other comparators (i.e. no treatment or conservative care), essential for
minimising selection and performance bias [4, 5]. However, despite.B. Anderson).
2 March 2019; Accepted 2 May
is an open access article under tthese benefits, placebo controls remain infrequently used to investigate
the efficacy of surgical interventions. A recent systematic review iden-
tified only 53 randomised placebo-controlled trials of surgery published
up until 2013 [6]. In approximately half (n ¼ 27; 51%), surgery was not
superior to placebo, questioning the continual use of the investigated
procedure. The review also found that placebo surgical interventions
were associatedwith less frequent and less severe adverse events than the2019
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that an invasive placebo is associated with greater risk than the investi-
gated intervention, a belief often presented as a barrier to trial partici-
pation [7, 8].
A recent review of 62 studies reporting data on participation in
randomised trials of surgical interventions found that non-recruitment
rates are as high as 92% for some trials [9]. The main reasons for
non-participation included preference for one form of treatment over the
other, dislike of randomisation and refusal to be in a non-treatment arm
[9]. Patients were also less willing to participate in trials that included a
placebo arm [9]. In another study that included 53 participants with
Parkinson's disease, 35 (66%) indicated they would be willing to
participate in a placebo controlled trial of surgery to treat their condition
[7]. Those who were willing to participate were more educated, while
those who were not, appeared to be focused on the perceived invasive
and risky nature of the placebo procedure. In another study by Mittal et
al, investigating reasons for or against participation into surgical rand-
omised controlled trials, they found higher education levels were asso-
ciated with decreased willingness to participate [10]. Mittal et al also
found that altruism was a motivator towards patient participation in
randomised controlled trials [10].
In order to determine the feasibility of a planned randomised placebo-
controlled surgical trial of decompression for lumbar spinal stenosis, we
performed a survey of the target population. Lumbar spinal stenosis is the
most common indication for spinal surgery in older adults [11, 12], and
currently has limited evidence suggesting it is more effective than con-
servative care [13, 14]. The aim of our study was to determine the pro-
portion of potentially eligible patients who would agree to participate in
a placebo-controlled trial, and any barriers to participation. We also
investigated what (if any) demographic and/or clinical characteristics
predict willingness to participate in order to inform recruitment strate-
gies for the planned trial.
2. Methods
2.1. Recruitment procedure
Consecutive eligible participants were recruited from two private
surgical practices in New South Wales and Victoria, Australia between
November 2015 and August 2016. Following a clinical and radiologic
assessment to determine that a patient with central lumbar spinal canal
stenosis was suitable for surgical decompression, two study surgeons
discussed the risk and benefits of the procedure. The surgeons then
outlined the design of a randomised placebo-controlled surgical trial, and
invited patients to participate in the survey. Those who consented were
contacted by study researchers who discussed the study details and
provided them with a link via email to the online survey. Consent to
participate in the survey was obtained online. Ethics approval was
granted by The University of Sydney Human Research Ethics Committee
(#2015/557).
2.2. Participants
To be included, participants needed to be older than 18 years of age;
diagnosed with central lumbar spinal canal stenosis (confirmed by im-
aging and clinical assessment); be considered by the treating surgeon to
be suitable for lumbar decompression; have access to the internet via a
computer, tablet or smartphone; and consent to participate. Participants
were excluded if they had any known or suspected serious spinal pa-
thology (e.g. fracture, metastatic, inflammatory or infective diseases, or
widespread neurological disorder).
2.3. Survey
Consenting participants completed an online survey. Demographic
data requested included age, gender, education level (completed year 102
or less, completed year 11 or 12, Technical and Further Education
(TAFE)/University not completed, TAFE completed, completed higher
University or higher), marital status (married, divorced/separated, sin-
gle/never married, widowed), employment status (yes, no) and occupa-
tion (manager, technician or trade worker, clerical or administrative
worker, machinery operator or driver, professional, community/personal
service worker, sales worker, labourer).
Clinical data collected included imaging used for diagnosis (x-ray,
computed tomography and/or magnetic resonance imaging (MRI)), use
of medication, pain and disability. Pain severity was measured by asking
“how much leg pain have you had during the last week?”, with partici-
pants given the options: none, very mild, mild, moderate, severe, or very
severe. Disability was measured by asking participants to rate how pain
interfered with normal life in the past week (not at all, a little bit,
moderately, quite a bit, or extremely). Both the pain and disability
questions were items from the Short-form (36) Health Survey
questionnaire.
Willingness to participate in a placebo-controlled trial of decom-
pression for lumbar spinal stenosis was investigated through a series of
closed-ended questions with yes or no responses. Participants were
asked if they understood when trials are needed, use of placebo surgery
in controlled trials and in trials specifically for lumbar spinal stenosis.
They were then asked if they would be willing to participate in a study
investigating the effects of surgery for lumbar spinal stenosis, and if they
would still be willing to participate if the trial randomised half the
participants to receive placebo surgery (included a "maybe" response
option). Finally they were asked if they were allocated to and received
placebo surgery, whether or not they would be willing to wait for six
months after their placebo surgery before receiving traditional surgery
(also included a "maybe" response option). Depending upon their re-
sponses, they were asked a series of open-ended questions to explore
their barriers to participation.
The survey questions were based upon previous research into patient
attitudes to placebo trials7 15 and piloted on both researchers and sur-
geons. Data were captured using an online server (REDCap) and exported
to STATA, V. 14 for statistical analysis [16].2.4. Analysis
Descriptive analyses were conducted for all demographic and clinical
data. Participants’ responses to the closed-ended questions were reported
as frequencies and percentages. The association between acceptability of
placebo-controlled trials and willingness to participate in a clinical trial
or placebo-controlled trial and age, gender, marital status, employment
status, educational level, pain and disability severity were each examined
using logistic regression analyses. Confidence Intervals were set at 95%
(95% CI) with outcomes reported as an Odds Ratio (OR). A p-value of less
than 0.05 was used for indicating statistical significance.
Outcomes with multiple responses were re-categorised for the pur-
poses of the analyses. Leg pain severity responses were re-categorised
into three groups: no to mild pain, moderate pain, and severe to very
severe pain; disability responses were dichotomised into not at all to
moderately disabled, and quite a bit to extremely disabled; and education
level was dichotomised into higher education completed or not
completed. Age was also converted into a binary variable: 65 years and
>65 years of age.
Two independent investigators (EM, GM) coded the responses to the
open-ended questions using a qualitative coding system [17]. This
allowed for a highly systematic abstraction of the data into categories and
subcategories defined by decision rules and positive examples, that
focused on relevance to the research question [17]. The two in-
vestigators' versions were discussed and combined into one final coding
frame. A third independent researcher (MF), arbitrated. Cohen's Kappa
was calculated for inter-rater agreement of all coded answers, with scores
>0.81 considered very-high agreement [18].
Table 2
Numbers (percentages) of yes or maybe responses where relevant to the
knowledge and willingness to participate questions.
Question N (%)
Do you understand that when the benefits of a particular treatment are uncertain a
clinical study (trial) is needed?
Yes 59 (95.2)
Did you know that some clinical trials use placebo surgery as a control (comparison) to
the traditional surgery?
Yes 28 (45.2)
Do you understand what placebo surgery for lumbar spinal stenosis is?
Yes 19 (30.6)
If you were invited to participate in a study investigating the effects of surgery for
lumbar spinal stenosis, would you be willing to participate?
Yes 42 (67.7)
If this study would involve patients to be randomly divided equally into two groups (by
chance), one group receiving surgery and the other group receiving a placebo
surgery, would you still be willing to participate?
Yes 10/42 (23.8)
Maybe 13/42 (30.9)
If you were allocated to a placebo surgery group, and later decided you would like to
receive traditional surgery, would you be willing to wait for six months to do so?
Yes 12 (20.0)
Maybe 13 (21.7)
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3.1. Participants characteristics
Of the 68 participants invited to participate in the study, 63
completed the survey (92.6%). Their demographic and clinical charac-
teristics are shown in Table 1.
3.2. Patients’ perspectives
Table 2 presents the results of the participant's responses to the
participation in placebo-controlled clinical surgical trials.
3.3. Associations with willingness to participate
Compared with those reporting lower levels of disability, people
describing ‘quite a bit’ to ‘extreme’ levels of disability demonstrated
more than three times the odds of being willing to participate in a clinical
trial for lumbar spinal stenosis (OR: 3.6; 95% CI, 1.2 to 11.4; P ¼ 0.03)
(Table 3). No other independent predictors of willingness to participate
in a clinical trial for lumbar spinal stenosis were identified. Compared
with those who were not married, people who were married had lower
odds of being willing to be randomised (one group receiving surgery and
the other group receiving a placebo surgery) in a placebo-controlled trial
for lumbar spinal stenosis (OR: 0.2; 95% CI, 0.05 to 0.8; P ¼ 0.03)
(Table 3). There were no other independent predictors of willingness to
participate in a placebo-controlled trial of surgery for lumbar spinal
stenosis.
3.4. Participants’ reasons and beliefs behind participation
There were 215 responses to the open-ended questions. The inter-
rater agreement of coding of these answers was Kappa value of 0.78 (pTable 1
Participant characteristics, N ¼ 63.












Not employed/Retired 44 (71.0)
Manager 4 (21)
Technician or trade worker 2 (11)
Machinery operator or driver 2 (11)
Professional 7 (37)
Community/Personal service worker 1 (5)
Sales worker 2 (11)









Very severe 6 (9.7)
Disability status*
Not at all disabled 6 (9.7)
A little bit disabled 10 (16.1)
Moderately disabled 15 (24.2)
Quite a bit disabled 24 (38.7)
Extremely disabled 7 (11.3)
* missing 1 participant data.
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< 0.001) with an asymptotic standardized error of 0.03. The final sum-
marised responses are shown in Table 4.
4. Discussion
The results from this survey provide insight into the barriers to, and
willingness of participation in randomised placebo-controlled spinal
surgical trials among patients with lumbar spinal stenosis. Almost all
participants (95.2%) acknowledged the need to conduct clinical trials to
evaluate treatments with unknown efficacy and 15.9% (n¼ 10) were also
willing to be randomised to a placebo surgical group. The level of will-
ingness decreased when asked if they would be happy to participate in a
clinical trial of decompressive surgery.
When participants were asked if they understood what placebo sur-
gery for lumbar spinal stenosis was, less than one third agreed. This may
explain why one third of the participants who supported being involved
in a clinical trial were uncertain if they would participate in a randomised
placebo-controlled trial of surgery. Results from the open-ended ques-
tions support this, with approximately one third of the responders stating
that with more information or reassurance of outcomes (with placebo)
they would have an increased willingness to participate. Additionally,
given only a minority of the responders stated that there were no reasons
that would increase their willingness to participate, it is likely that the
majority of participants were open to participation.
Responses to the open-ended questions suggest that uncertainty or
unwillingness to participate in a randomised placebo controlled surgical
trial stems from a concern of the risks associated with surgery (e.g.
infection) and of having an unknown outcome (if they receive placebo).
Given placebo surgical trials are safe [6], and placebo surgery itself is
associated with fewer risks and complications in placebo trials of surgery
[6], there may be potential for a greater willingness to participate
amongst these participants if the correct information is provided.
Considering the low proportion of participants expressing a willingness
to be randomised in a placebo-controlled surgical trial, further education
of potential participants would both reassure potential participants of
their concerns for a randomised placebo-controlled surgical trial for
lumbar spinal stenosis and improve recruitment rates.
The data analysis demonstrated that increased disability was the only
factor associated with willingness to participate in a clinical trial of
surgery, but it was not associated with willingness to be part of a rand-
omised placebo-controlled trial. Increased education levels had no as-
sociation with willingness to participate in a clinical trial or a randomised
placebo-controlled trial. This was in contrast to previous research [9]
Table 3
Association with participants’ willingness to participate in a clinical trial and a randomised placebo-controlled trial for lumbar spinal stenosis.
Willingness to participate in clinical trial for lumbar spinal stenosis* Willingness to be randomised to placebo surgery▴
N OR (95% CI) p value N OR (95% CI) p value
Age
65 13 Reference 13 Reference
>65 49 0.6
(0.1–2.3)
0.43 48 0.6 (0.05–2.6) 0.47
Employment status
Not employed 44 Reference 43 Reference
Employed 17 1.9 (0.5–7.8) 0.38 17 1.9 (0.5–7.8) 0.38
Marital status
Not married 18 Reference 18 Reference
Married 44 0.7 (0.2–2.5) 0.63 43 0.2 (0.05–0.8) 0.03
Gender
Male 30 Reference 30 Reference
Female 32 0.8 (0.3–2.4) 0.71 31 1.0 (0.2–3.7) 0.96
Education level
Higher education not completed 31 Reference 30 Reference
Higher education completed 30 1.0 (0.3–2.8) 0.92 30 0.4 (0.1–2.0) 0.29
Pain 0.11 0.47
No to mild pain 17 Reference 16 Reference
Moderate pain 24 2.7 (0.7–10) 0.13 24 3.9 (0.4–37.5) 0.23
Severe to very severe pain 20 4.5 (1.0–19.2) 0.04 20 3.7 (0.4–37.4) 0.26
Disability
No at all to moderately disabled 30 Reference 29 Reference
Quite a bit to extremely disabled 31 3.6 (1.2–11.4) 0.03 31 2.5 (0.6–11.0) 0.21
OR ¼ Odds ratio; 95% CI ¼ 95% Confidence Interval.
* 1 participant did not respond to this question.
▴ 2 participants did not respond to this question.
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placebo-controlled surgical trial, and reported higher-education levels
were associated with an increased willingness to participate. In our
survey, marital status was the only category with a statistically signifi-
cantly association with participants’ willingness to participate in a
randomised placebo-controlled surgical trial. There was no insight from
the open ended-ended questions to explain this, and it is possible that thisTable 4
Summarised themes for responses to open-ended questions.
Participants' general opinions towards placebo surgery in clinical trials
Do not see any value/benefit in placebo surgery
Have concerns about placebo surgery (e.g. ethical, costs)
Have not formed an opinion yet (e.g. due to lack of information)
Understand the importance and benefits of placebo surgery
Other
Reasons participants gave for responding no or maybe to participation in a randomised place
Have concerns about the risks and benefits of placebo surgery
Have a lack of information or understanding about placebo surgery
Have unmodifiable personal reasons against placebo surgery
Have a clear preference for treatment
Have financial and/or ethical concerns on the cost of the surgery
Understand the importance of placebo surgery in clinical trials and/or want to contribute t
Other (disagree with any kind of surgery or answers not interpretable)
Factors that would increase willingness to participate in a placebo-controlled trial
More information about procedure and/or study
Certainty and reassurance of good outcome
Free choice of which treatment received
Pain levels or functional status
Advantages to participation
Support of clinical evidence
Nothing/unlikely to improve willingness
Other
Reasons participants gave against waiting 6 months for surgery (if allocated to placebo group
Do not see the value of randomised trials or only want surgery
Need reassurance about positive outcomes after placebo surgery
Level of pain and functional status




was a chance finding or type I error. It is also possible that being married
reflects unmeasured behaviours and beliefs regarding risk. The lack of
willingness present in this surveyed population may be explained by the
lack of understanding among the participants of what placebo surgery is
and the structure and importance of placebo trials and misunderstanding
of the associated risks. Educating the community and potential partici-
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4.1. Study limitations
Limitations in this study included the small sample size. The small
number of participants willing to participate (N ¼ 10) was also a limi-
tation, as it decreased the power of the logistic regression for that
response. Interpretation of the responses to the open-ended question was
also a limitation, as they can be subjective. We did limit this however, by
having multiple reviewers, and by having them trained in how to inter-
pret open-ended responses. We also had a third reviewer to resolve any
disagreements.
5. Conclusion
This survey has provided modest insight into both patients' attitudes
to a placebo-controlled surgical trial for lumbar spinal stenosis and their
rationale for these beliefs. Although there was a relatively low level of
willingness to participate amongst the participants surveyed, this was
likely based upon the participants’ concerns about the safety and un-
known treatment outcomes of placebo trials. It is therefore suggested
placebo-controlled surgical trials consider educating potential partici-
pants to both the risks, and the likely benefits of these trials. This may
assist in reassuring participants that placebo-surgical trials are relatively
safe, associated with fewer complications, and are necessary to deter-
mine effectiveness of procedures with subjective outcomes. This
approach may also improve recruitment into these trials, which remains
a difficulty for researchers of clinical trials. Given the low sample size
present in this study, all results should be interpreted with caution.
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